Primary therapy and survival among patients with nodular lymphocyte‐predominant Hodgkin lymphoma: a population‐based analysis in the Netherlands, 1993

Primary therapy and survival among patients with nodular lymphocyte‐predominant Hodgkin lymphoma: a population‐based analysis in the Netherlands, 1993–2016

Published:2019-11-04 Issue:1 Volume:189 Page:117-121
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Posthuma Hidde L. A.¹^ORCID,Zijlstra Josée M.¹,Visser Otto²,Lugtenburg Pieternella J.³^ORCID,Kersten Marie José⁴⁵,Dinmohamed Avinash G.¹⁴⁶⁷^ORCID

Affiliation:

1. Department of Haematology Cancer Center Amsterdam Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam The Netherlands

2. Department of Registration Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht The Netherlands

3. Department of Haematology Erasmus MC Cancer Institute RotterdamThe Netherlands

4. Department of Haematology Cancer Center Amsterdam Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

5. Lymphoma and Myeloma Center Amsterdam (LYMMCARE) Amsterdam The Netherlands

6. Department of Research Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht The Netherlands

7. Department of Public Health Erasmus University Medical Center Rotterdam The Netherlands

Funder

NCR

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16290

Reference15 articles.

1. Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival

2. European task force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes;Anagnostopoulos I.;Blood,2000

3. Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma

4. Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up

5. Interpreting trends in cancer patient survival

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies;Blood;2023-08-10

2. Expanding the bacterial origins of nodular lymphocyte-predominant Hodgkin lymphoma;Haematologica;2023-06-29

3. Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?;Cancers;2023-06-23

4. Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment;Expert Review of Hematology;2023-06-20

5. Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi;HemaSphere;2023-04